Gilead Sciences, Inc. (NASDAQ:GILD)' shares surged over 5% in after-hours trading on Thursday after the company announced its second-quarter earnings before giving up some of...
Keep Reading →
July 29 - News
Most people under the age of 35 don't put a lot of thought into their retirement. These people couldn't be more misguided.
Keep Reading →
July 29 - News
Since 1992, my family has held season tickets for the Milwaukee Brewers.
Keep Reading →
July 29 - News
Multiple myeloma is a cancer of plasma cells, a type of white blood cell present in bone marrow.
Keep Reading →
July 26 - News
Obamacare was originally planned to kick in next year.
Keep Reading →
July 26 - News
AbbVie Inc (NYSE:ABBV) will release its quarterly report on Friday, and with its stock having jumped considerably since it started trading as a separate entity, investors are ...
Keep Reading →
July 24 - News
Uncertainty creates opportunity for long-term investors, and there is a lot of uncertainty in the healthcare sector right now.
Keep Reading →
July 24 - News
By age 35, around two-thirds of all American men will have begun to experience androgenetic alopecia, more commonly known as male pattern baldness.
Keep Reading →
July 24 - News
Picking the best dividend stocks isn't just a matter of finding the highest-yielding picks.
Keep Reading →
July 23 - News
Big pharma placed its bets on a new class of diabetes drugs called SGLT2. Last year, buzz surrounded late-stage projects from Johnson and Johnson (NYSE:JNJ), Eli Lilly & Co.
Keep Reading →
July 22 - News
With the SPDR S&P Biotech Index up 31% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Keep Reading →
July 22 - News
According to multiple reports , Harvard researchers Timothy Henrich and Daniel Kuritzkes have recently noted a surprising side-effect to cancer treatments performed on two separate...
Keep Reading →
July 22 - News
Part of the difficulty with analyzing equities is assessing the international strength of the economy.
Keep Reading →
July 19 - News
In an industry where buyouts are commonplace and small-cap biotechs burn through cash rapidly, optimizing operating cash flow can be essential to a company's financial health.
Keep Reading →
July 19 - News
This series, brought to you by Yahoo! Finance, looks at which upgrades and downgrades make sense, and which ones investors should act on.
Keep Reading →
July 19 - News
Johnson & Johnson (NYSE:JNJ) reported its second quarter on Tuesday, and turned in some positive numbers. Revenue grew 8.5%, year-over-year, up to $17.9 billion.
Keep Reading →
July 19 - News
Weather can be awful, with hurricanes, tornadoes, or other extreme storms.
Keep Reading →
July 19 - News
There’s a lot to notice from Johnson & Johnson (NYSE:JNJ)’s earnings -- the company announced a very solid quarter.
Keep Reading →
July 17 - News
Johnson & Johnson (NYSE:JNJ) today reported second-quarter results that had shareholders smiling.
Keep Reading →
July 17 - News
Big-time earning reports earlier this week, but for the most part, we have seen very little movement.
Keep Reading →
July 17 - News
Recently, Prestige Brands Holdings, Inc.
Keep Reading →
July 17 - News
After World War Two, The United States of America witnessed the largest population increase in its history.
Keep Reading →
July 17 - News
In mid July, Fisher Asset Management, the asset management firm run by billionaire and Forbes columnist Ken Fisher, filed its 13F for the second quarter of 2013 with the SEC, ...
Keep Reading →
July 16 - Hedge Funds
The major U.S. markets are moderately lower this afternoon. As of 12:50 p.m.
Keep Reading →
July 16 - News
Johnson & Johnson (NYSE:JNJ) is scheduled to release its quarterly earnings report tomorrow, and as a huge health-care conglomerate with a strong presence in consumer health-care...
Keep Reading →
July 16 - News
Arthritis biologics like Remicade, Enbrel, and Humira are pricy drugs that many of the 50 million American arthritis patients – and hundreds of millions of patients worldwide...
Keep Reading →
July 16 - News
With the SPDR S&P Biotech Index up 33% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Keep Reading →
July 15 - News
Dividend stocks have gotten incredibly popular among investors as the search for income has led many to take on more risk in their portfolios in order to generate the cash flow...
Keep Reading →
July 15 - News
In July 2012, the Food and Drug Administration Safety and Innovation Act was signed into law; and little did we know at the time, but the drug development process was about to...
Keep Reading →
July 12 - News
Pharmacyclics, Inc. (NASDAQ:PCYC) and development partner Janssen, a division of Johnson & Johnson (NYSE:JNJ), announced on Wednesday that a New Drug Application, or NDA, has...
Keep Reading →
July 11 - News
Over the past year, Intuitive Surgical, Inc. (NASDAQ:ISRG) has been mired in a mix of controversy pertaining to the safety of its revolutionary da Vinci surgical robots.
Keep Reading →
July 10 - News
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...
Keep Reading →
July 10 - News
Even if you’re bullish on the market, downside risks exist.
Keep Reading →
July 10 - News
The broader indices have gone through some choppy seas lately.
Keep Reading →
July 9 - News
Over the next few weeks I'll be taking an in-depth look at each one of the Dow Jones Industrial Average (INDEXDJX:.DJI)'s nine dividend aristocrats.
Keep Reading →
July 8 - News
Dividend stocks outperform non-dividend-paying stocks over the long run.
Keep Reading →
July 8 - News
We as a country have a come a long way over the past two decades with regard to treating HIV and reducing the number of AIDS diagnoses.
Keep Reading →
July 8 - News
When it comes to investing for the long term, sometimes companies that are thought of as “stable” or “boring” turn out to be the best thing for your portfolio.
Keep Reading →
July 5 - News
Health care is one of those industries where potential for high returns is increasing.
Keep Reading →
July 5 - News
The bond market hasn’t been the greatest place to be for the average investor.
Keep Reading →
July 5 - News
Technically, Abbott Laboratories (NYSE:ABT) has been around for decades.
Keep Reading →
July 3 - News
What’s the worst nightmare of all pharmaceutical companies? Generics. They might as well be the grim reaper in the eyes of the brand-name pharmaceuticals.
Keep Reading →
July 2 - News
When looking for the best dividend stocks, it's usually best to not chase the highest dividend.
Keep Reading →
July 2 - News
The final catalyst is the one that I am reviewing today. I am looking at two companies that look to be attractive acquisition targets.
Keep Reading →
July 1 - News
AbbVie Inc (NYSE:ABBV) has risen more than 20% since it hit the market earlier this year. In fact, it has managed to beat the S&P 500 by nearly 10%.
Keep Reading →
July 1 - News
Large conglomerates are generally low-beta blue chips that effectively reduce the risk attached to a portfolio.
Keep Reading →
July 1 - News
To prove my point, I looked at the multi-year chart and picked out some of the peaks.
Keep Reading →
July 1 - News
Merck & Co., Inc. (NYSE:MRK) stock has become dependent on its diabetes drug Januvia over the past couple of years for revenue growth.
Keep Reading →
July 1 - News
Recently, corporate America has been faced with a problem.
Keep Reading →
July 1 - News
